Social Support Intervention for Cancer Caregivers
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program called enCompass Carolina, designed to support caregivers of cancer patients in rural areas. The goal is to assess the usefulness and effectiveness of this social support program for caregivers who may feel isolated from healthcare resources. The study seeks unpaid caregivers who assist someone with cancer, especially those living in rural areas. The trial will gather feedback to improve how caregivers find and use support networks. As an unphased trial, it offers caregivers an opportunity to contribute to developing vital support systems that can enhance their caregiving experience.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on social support rather than medication changes.
What prior data suggests that this social support intervention is safe for cancer caregivers?
Research has shown that enCompass Carolina, a support program for cancer caregivers, is safe because it emphasizes coaching and support over medical treatment. Studies have evaluated its effectiveness and acceptability, aiming to provide caregivers with guidance and resources. No reports of problems or safety issues have emerged, as the program is non-invasive and centers on emotional and practical support. Without medical procedures involved, participants can expect a low-risk experience designed to enhance their caregiving journey.12345
Why are researchers excited about this trial?
Researchers are excited about the Social Support Intervention for Cancer Caregivers because it emphasizes a unique approach to supporting caregivers, which is often overlooked in traditional cancer care. Unlike standard treatments that primarily focus on the patient, this intervention targets the well-being of caregivers, providing them with essential social support and resources. This approach aims to improve the caregivers' mental health and resilience, ultimately benefiting both the caregiver and the person with cancer. By focusing on rural-dwelling caregivers, the intervention also addresses a gap in care accessibility, tailoring support to those who might otherwise be isolated from such resources.
What evidence suggests that the enCompass Carolina intervention is effective for cancer caregivers?
Research shows that the enCompass Carolina program, studied in this trial, aims to help caregivers of cancer patients by connecting them with new support resources. Early results suggest that programs like enCompass can improve caregivers' well-being. The program specifically seeks to reduce stress and increase access to resources for those in rural areas, where support options may be limited. It builds on previous successful programs and shows promise in helping caregivers manage their duties more effectively. While detailed data on enCompass Carolina's effectiveness is still being collected, its approach relies on proven models that have helped caregivers in similar situations.12367
Who Is on the Research Team?
Erin E Kent, PhD, MS
Principal Investigator
Department of Health Policy and Management Gillings School of Global Public Health
Are You a Good Fit for This Trial?
This trial is for caregivers of cancer patients with stage II-IV solid tumors or hematologic malignancies, who are receiving active treatment and live in rural areas. Caregivers must be adults, speak English, provide consent, and commit to the study's procedures. Patients' caregivers must also enroll in the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Caregivers participate in the enCompass Carolina social support intervention
Follow-up
Participants are monitored for feedback and effectiveness of the intervention
What Are the Treatments Tested in This Trial?
Interventions
- enCompass Carolina
Find a Clinic Near You
Who Is Running the Clinical Trial?
UNC Lineberger Comprehensive Cancer Center
Lead Sponsor
The Duke Endowment
Collaborator